2016
DOI: 10.1038/nrd.2016.109
|View full text |Cite
|
Sign up to set email alerts
|

Twenty years on: the impact of fragments on drug discovery

Abstract: After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream. More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials. FBDD has been widely applied in both academia and industry, as evidenced by the large number of papers from universities, non-profit research institutions, biotechnology companies and pharmaceutical companies. Moreover, FBDD draws on a diverse range of disciplines, from biochemist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
824
0
9

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 821 publications
(871 citation statements)
references
References 107 publications
5
824
0
9
Order By: Relevance
“…Possible strategies include: 1) Copying Nature and using repetitive coupling chemistries to easily build different systems out of a family of building blocks (peptidomimetics); 43 2) Embracing robotic/automation for targeted syntheses and/or accelerated serendipity approaches 114 to host design; 3) Using fragment-based approaches and structurebased design. 115 Within the physical community, one ongoing debate involves the solvation of proteins and how this influences their properties. There is good evidence that the large-amplitude motions of proteins are mediated by the translational diffusion of water.…”
Section: Recognition Mimicry and Interactions With Biomoleculesmentioning
confidence: 99%
“…Possible strategies include: 1) Copying Nature and using repetitive coupling chemistries to easily build different systems out of a family of building blocks (peptidomimetics); 43 2) Embracing robotic/automation for targeted syntheses and/or accelerated serendipity approaches 114 to host design; 3) Using fragment-based approaches and structurebased design. 115 Within the physical community, one ongoing debate involves the solvation of proteins and how this influences their properties. There is good evidence that the large-amplitude motions of proteins are mediated by the translational diffusion of water.…”
Section: Recognition Mimicry and Interactions With Biomoleculesmentioning
confidence: 99%
“…13 That journey represents a milestone in drug discovery science, in that it entailed the first successful application of the so-called SAR by NMR (structureactivity relation by nuclear magnetic resonance) technology to tackle a very challenging protein-protein interaction target, an accomplishment recently recognized with the 2017 Prix Galien. 14 In addition to the countless scientific, technical, medical and other professionals who contributed to that drug, Abbvie management also deserves praise for allowing protracted investment in the Bcl-2 inhibitor program over a time frame that few companies would have courage to continue.…”
mentioning
confidence: 99%
“…It is possible that current screening libraries do not contain an appropriate complementary chemical space. Over the last twenty years, fragment‐based drug discovery (FBDD) has emerged as a powerful, complementary method for the generation of new chemical hits 5. Typical high‐throughput screening methods attempt to identify potent chemical leads (<10 μ m ) by screening upwards of millions of rule‐of‐five compliant small molecules (<500 Da) 6.…”
mentioning
confidence: 99%